Cigna funds breast cancer drug

Cigna Healthcare is funding the use of Herceptin for sufferers of early stage breast cancer, in conjunction with Healthcare at Home.
Currently, the NHS only provides the drug for advanced stage HER2 breast cancer.
Sharon Lyons, Cigna Healthcare managing director, said the move was a logical and sound response to recent positive medical trials.